The explosion of data volumes in enterprise environments and limited budgets have triggered the need for multi-tiered storage systems. With the bulk of the data being extremely infrequently accessed, tape is a natural fit for storing such data. In this paper we present our approach to a file storage system that seamlessly integrates disk and tape, enabling a bottomless and cost-effective storage architecture that can scale to accommodate Big Data requirements. The proposed system offers access to data through a POSIX filesystem interface under a single global namespace, optimizing the placement of data across disk and tape tiers. Using a self-contained, standardized and open filesystem format on the removable tape media, the proposed system avoids dependence on proprietary software and external metadata servers to access the data stored on tape. By internally managing the tape tier resources, such as tape drives and cartridges, the system relieves the user from the burden of dealing with the complexities of tape storage. Our implementation, which is based on the GPFS and LTFS filesystems, demonstrates the applicability of the proposed architecture in real-world environments. Our experimental evaluation has shown that this is a very promising approach in terms scalability, performance and manageability. The proposed system has been productized by IBM as LTFS Enterprise Edition.
Zusammenfassung: Die Behandlung ausgeprägter glenoidaler Knochendefekte ist herausfordernd. Patientenindividuelle glenoidale Implantate stellen diesbezüglich ein neues Verfahren dar, welches mit enormen potenziellen Vorteilen behaftet ist. Die eigenen Erfahrungen zeigen, dass mit dieser Technologie einerseits der glenoidale Knochendefekt reproduzierbar wiederherzustellen ist und andererseits eine stabile Verankerung und eine hochpräzise Implantatpositionierung entsprechend der präoperativen Planung erzielt werden kann. Dies stellt sich besonders im Vergleich zu Alternativverfahren, wie der knöchernen Glenoidaugmentation, als substanzieller Vorteil der Technik für diese häufig hochdefizitären und anspruchsvollen Situationen dar. Nach Durchführung einer Computertomographie (CT) der Schulter wird präoperativ das individuelle Implantatdesign dreidimensional detailliert computergestützt geplant. Von zentraler Bedeutung für die korrekte und planungsgetreue Positionierung des definitiven Implantats während der Operation ist eine präzise Einbringung eines Kirschner-Drahts mittels PSI(„patient specific instrumentation“)-Guide.. Nach Fixation der glenoidalen Komponente kann diese mit Standardimplantaten des jeweiligen Systems kombiniert werden. Die aktuell vorhandene Literatur ist ermutigend und zeigt, dass kurzfristig signifikante klinische Erfolge mit dem Verfahren erzielbar sind. Weitere Forschung im Sinne von biomechanischen Untersuchungen und längeren Nachuntersuchungszeiträumen ist wünschenswert, um die Wertigkeit des Verfahrens weiter zu präzisieren.
Severe glenoid bone loss remains a major challenge in reverse total shoulder arthroplasty, as conventional implants often fail to achieve stable fixation. Three-dimensional (3D) printed, custom-made glenoid implants provide a patient-specific solution by optimizing bone–implant congruence, fixation strategy, and biomechanics. This narrative review synthesizes biomechanical principles and surgical considerations underpinning custom glenoid design, including central peg fixation, porous surfaces, bone–implant contact area, and the importance of computed tomography-based pre-operative planning. Current evidence suggests that implant stability is improved by secure central fixation, porous press-fit interfaces, and avoidance of excessive lateralization, which increases torque and failure risk. Custom implants allow tailored peg and screw placement to enhance fixation in compromised bone. Further studies are required to validate these principles and define long-term outcomes.
29 May 2026 in Journal of Shoulder and Elbow Arthroplasty
Custom-made glenoid implants (CMGIs) represent a new technology for treating severe glenoid bone deficiencies. Despite the potential advantages of achieving sufficient primary stability and precise implant positioning, its role is not clear due to the scarcity of clinical studies. The first 12 consecutive patients who were treated with CMGIs (ProMade, Enovis) at a single institution were enrolled. At a minimum follow-up (FU) of 2 years (range: 24-76 months; mean 36 months), the clinical outcomes were evaluated using the Constant score, Simple Shoulder Test, and range of motion and compared with pre-operative values. Radiographs were assessed for inferior notching, osteolysis, or other signs of loosening. All complications were recorded. There was a significant improvement in Constant score (26 to 71 [P < .001]), Simple Shoulder Test (1.9 to 8.5 [P < .001]), and range of motion in all degrees of freedom (P < .05). There were no radiological signs of osteolysis or loosening. Thirty percent of patients were noted to have grade 1 notching. Two patients were not eligible for a 2-year FU (death from unrelated conditions, recurrent infection). An overall complication rate of 25% included dislocation (n = 1), hematoma (n = 1), and a nondisplaced fracture of the humerus (n = 1). CMGIs are an option for the treatment of severe glenoid bone deficiencies at a short- to medium-term follow-up with promising clinical results and no adverse radiological signs. The complication rate is not insignificant, and further studies with longer-term follow-up are suggested.